Our vision
The overarching objective of Neuro-SysMed is to improve the treatment of multiple sclerosis (MS), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and dementia. To achieve this goal, the Centre is establishing a state-of the-art clinical trial unit and conducting groundbreaking clinical and translational studies involving health care institutions across Norway and
international partners.
Clinical trials
Neuro-SysMed will organize and conduct randomized clinical treatment trials to evaluate the efficacy and safety of therapies, novel or established drugs with new indications, that may delay or even arrest disease progression, ameliorate symptoms or optimize care for affected individuals.
Partners
